Clinical Trial Update: CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis

View source ↗

Summary

This clinical trial update reports on studying the effects of CFTR modulator therapy on bone density and muscle in adults with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Osteoporosis
• Sarcopenia

Drugs mentioned

• Trikafta (elexacaftor/tezacaftor/ivacaftor) (elexacaftor/tezacaftor/ivacaftor)

Snippet

Sponsor: Indiana University | Conditions: Cystic Fibrosis, Bone Loss | Status: ACTIVE_NOT_RECRUITING